Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 9, 1996, Pages 925-927

  Blanshard, Christine ^a   Pasi, John ^a   Rolles, Keith ^a   Davidson, Brian ^a   Jain, Stephan ^b   Burroughs, Andrew ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

Activated protein C; Budd Chiari syndrome; Factor V Leiden; Liver transplantation; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; THROMBOCYTE FACTOR 5;

ADULT; ARTICLE; BLOOD CLOTTING; BUDD CHIARI SYNDROME; CASE REPORT; FEMALE; HOMOZYGOSITY; HUMAN; LIVER NECROSIS; LIVER TRANSPLANTATION; MYELOPROLIFERATIVE DISORDER; PORTOCAVAL SHUNT; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; BLOOD COAGULATION TESTS; FACTOR V; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER TRANSPLANTATION; MUTATION; PROTEIN C;

EID: 0029782794     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dilawari JB, Brambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al.: Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine 1994, 73:21-35.
2. Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, et al.: Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985, 103:329-334.
3. Bauer KA: Pathobiology of the hypercoagulable state. Clinical features, laboratory evaluation and management. In Haematology: Basic Principles and Clinical Practice. Edited by Huffman R, Benz EJ, Santil SJ, Fine B, Cohen HJ. New York: Churchill Livingstone; 1991:1415-1430.
4. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognised mechanism characterised by poor coagulant response to activated protein C. Proc Natl Acad Sd USA 1993, 90:1004-1008.
5. Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994, 330:517-572.
6. Koster T, Rosendaal FR, de Ronde H, Briet E. Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993, 342:1503-1506.
7. Griffin JH, Evatt B, Wideman C, Fernandez JA: Anticoagulant protein C pathway defective in the majority of thrombophilic patients, Blood 1993, 82:1989-1993.
8. Halbmeyer W-M, Haushofer A, Schon R, Fischor M: The preva-lence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coag Fibrinol 1994, 5:51-57.
9. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirvon RJ, de Ronde H, et al.: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67
10. 506Gln mutation in factor Va. Lancet 1994, 343:1535-1536.
11. 506 of factor V. Lancet 1994, 343:1536-1538.
12. Sun X, Evatt B, Griffin JH: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994, 83:3120-3125.
13. Zoller B, Dahlback B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis, Lancet 1994, 343:1536-1538.
14. Henderson JM, Warren WD, Millikan WJ, Galloway JR, Kawasaki S, Stahl, RL, et al.: Surgical options, hematologic evaluation and pathologic changes in Budd-Chiari syndrome. Am J Surgery 1990, 159:41-50.
15. Hartert H: Thromboelastography. In Thrombosis and Bleeding Disorders. Theory and Methods. Edited by Bang NU, Beller FK, Deutch E, Mammen E. Stuttgart: Academic Press; 1971:70-85.
16. Mahmoud AEA, Wilde JT, Elias E: Budd-Chiari syndrome and factor V Leiden mutation. Lancet 1995, 345:526.
17. Denninger M-H, Beldjord K, Durand F, Denié C, Valla D, Guillin M-C: Budd-Chiari syndrome and factor V Leiden mutation. Lancet 1995, 345:525-526.
18. Greengard JS, Eichinger S, Griffin JH, Bauer KA: Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-Gln mutation in the gene for factor V. N Eng J Med 1994, 331:1559-1561.
19. Thompson NP, Miller AD, Hamilton G, Alexander GM, Friend PJ, Burroughs AK: Emergency rescue hepatic transplantation following shunt surgery for Budd-Chiari syndrome, Eur J Gastroenterol Hepatol 1994, 6:835-837.
20. Shaked A, Goldstein RM, Lasle A, Bauer E, von Segesser L, Lagardier F, et al.: Portosystemic shunt versus liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992, 174:453-459.
21. Oldhafer KJ, Ringe B, Wittekind C, Pilchmayr R: Budd-Chiari syndrome: portacaval shunt and subsequent liver transplant. Surgery 1990, 107:471-474.
22. Tracy PB, Eide LL, Bowie EJW, Mann KG: Radioimmunoassay of factor V in human plasma and platelets. Blood 1982, 60:59-63.
23. Cerveny JJ, Fass DN, Mann KG: Synthesis of factor V by cultured aortic endothelium. Blood 1984, 63:1467-1474.
24. Maruyama I, Salem HH, Majerus PW: Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest 1984, 74:224-230.